Among the downregulated master regulators, MYB and BCL11A have been related to immune system regulation in hematologic malignancies, suggesting their participation in the maintenance of the hematopoiesis and in the regulation of other downregulated master regulators such as IKZF1. The gene discussed is BCL11A; the disease is hematologic disorder.